Split-course radiotherapy: where do we stand?
Dubben HH, Krüll A, Beck-Bornholdt HP.
Strahlenther Onkol. 2001 May;177(5):227-39. doi: 10.1007/pl00002402.
Updated Outcomes of Split Course Radiotherapy in Elderly or Infirm Patients With Advanced Cancers of the Head and Neck.
Domb C, Smile TD, Reddy C, Woody NM, Campbell SR, Canavan JF, Joshi NP, Greskovich JF, Chute DJ, Burkey BB, Ku LA, Lamarre E, Lorenz RR, Prendes B, Scharpf J, Schwartzman L, Geiger JL, Koyfman SA, Fleming CW.
Anticancer Res. 2021 Oct;41(10):4995-5000. doi: 10.21873/anticanres.15313.
[Split-course radiotherapy or treatment interruption].
Feldmann HJ.
Strahlenther Onkol. 2000 Oct;176(10):458-61. doi: 10.1007/pl00002310.
Will personalized ultrafractionated stereotactic adaptive radiotherapy (PULSAR) or split-course SBRT based on systemic therapy (3S) be future directions in the Field of SBRT?
Zhou Z, Guan B, Lin J, Zheng R, Xu B.
Int Immunopharmacol. 2025 Jan 27;146:113689. doi: 10.1016/j.intimp.2024.113689. Epub 2024 Dec 24.
Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.
Paik EK, Kim MS, Seo YS, Jang WI, Kang JK, Cho CK, Yoo HJ.
Jpn J Clin Oncol. 2018 Jun 1;48(6):548-554. doi: 10.1093/jjco/hyy062.
Radical surgery and postoperative split-course radiotherapy in squamous cell carcinoma of the mobile tongue: factors influencing local control and the time to recurrence.
Kajanti M, Holsti LR, Holsti P.
Radiother Oncol. 1991 Nov;22(3):174-9. doi: 10.1016/0167-8140(91)90021-8.
Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases.
Benhmida S, Sun R, Gherga E, Hammoud Y, Rouvier J, Mauvais O, Bockel S, Louvrier A, Lebbad A, Bontemps P, Ortholan C, Bourhis J, Lestrade L, Sun XS.
Cancer Radiother. 2020 Dec;24(8):812-819. doi: 10.1016/j.canrad.2020.03.013. Epub 2020 Nov 2.
Split-Course Accelerated Hypofractionated Radiotherapy (SCAHRT): A Safe and Effective Option for Head and Neck Cancer in the Elderly or Infirm.
Bledsoe TJ, Noble AR, Reddy CA, Burkey BB, Greskovich JF, Nwizu T, Adelstein DJ, Saxton JP, Koyfman SA.
Anticancer Res. 2016 Mar;36(3):933-9.
An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.
Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, Schuller DE, Forastiere AA.
J Clin Oncol. 2003 Jan 1;21(1):92-8. doi: 10.1200/JCO.2003.01.008.
Split-course radiotherapy with or without concurrent or sequential chemotherapy in non-small cell lung cancer.
Ulutin HC, Güden M, Oysul K, Sürenkök S, Pak Y.
Radiat Med. 2000 Mar-Apr;18(2):93-6.
